The over-expression of p50 (NF-κB1) was observed in various malignancies [22], [23], including non-small cell lung carcinoma, colon cancer, prostate cancer, breast cancer, bone cancer, and brain cancer. The gene discussed is NFKB1; the disease is prostate carcinoma.